Global BioBreak is a members-only relationship building community intended to foster a stronger regional environment for executives in the life sciences and investors.
ARCHIVED EVENT: Global BioBreak
Tuesday
August 11, 2020
1:00pm-2:00pm (America/New York time)
August 11, 2020
1:00pm-2:00pm (America/New York time)
Event Details:
The "Deal Making Goes Virtual: A New Frontier” panel focuses on strategies for deal making on digital platforms as well as dive into some of the many changes in developing partnerships experienced during COVID-19. The panelists revealed their insights on what changes could be permanent and the impacts on strategic partnerships and deal making.
The panel discussed:
-Adjusting to virtual communications
-COVID-19’s impacts on the business development process
-Key factors that help companies’ close deals during COVID-19
-Success stories: deals made that took a critical team effort
Panelists:
Martin Lehr, Moderator, CEO, Context Therapeutics.
Dr. Colleen Cuffaro, Partner, Canaan Partners.
Melissa Epperly, CFO, Zentalis Pharmaceuticals.
Geoff Meyerson, CEO & Co-Founder, Locust Walk.
The "Deal Making Goes Virtual: A New Frontier” panel focuses on strategies for deal making on digital platforms as well as dive into some of the many changes in developing partnerships experienced during COVID-19. The panelists revealed their insights on what changes could be permanent and the impacts on strategic partnerships and deal making.
The panel discussed:
-Adjusting to virtual communications
-COVID-19’s impacts on the business development process
-Key factors that help companies’ close deals during COVID-19
-Success stories: deals made that took a critical team effort
Panelists:
Martin Lehr, Moderator, CEO, Context Therapeutics.
Dr. Colleen Cuffaro, Partner, Canaan Partners.
Melissa Epperly, CFO, Zentalis Pharmaceuticals.
Geoff Meyerson, CEO & Co-Founder, Locust Walk.
 |
BECOME A SUPPORTER
For more information about sponsorship, please email us at sponsorship@biobreak.org.